Stage IIIC Prostate Cancer AJCC v8 Recruiting Phase 3 Trials for Apalutamide (DB11901)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04134260Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate CancerTreatment
NCT04513717Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialTreatment